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Abstract
Background: Pseudomonas aeruginosa is an important opportunistic human pathogen and is extremely difficult to
treat due to its high intrinsic and adaptive antibiotic resistance, ability to form biofilms in chronic infections and
broad arsenal of virulence factors, which are finely regulated. TypA is a GTPase that has recently been identified to
modulate virulence in enteric Gram-negative pathogens.
Results: Here, we demonstrate that mutation of typA in P. aeruginosa resulted in reduced virulence in phagocytic
amoebae and human macrophage models of infection. In addition, the typA mutant was attenuated in rapid cell
attachment to surfaces and biofilm formation, and exhibited reduced antibiotic resistance to ß-lactam, tetracycline
and antimicrobial peptide antibiotics. Quantitative RT-PCR revealed the down-regulation, in a typA mutant, of
important virulence-related genes such as those involved in regulation and assembly of the Type III secretion
system, consistent with the observed phenotypes and role in virulence of P. aeruginosa.
Conclusions: These data suggest that TypA is a newly identified modulator of pathogenesis in P. aeruginosa and is
involved in multiple virulence-related characteristics.
Keywords: Pseudomonas aeruginosa, Pathogen, TypA, Type III secretion system, Virulence, Dictyostelium
discoideum, Macrophage, Biofilm, Resistance
Background
Pseudomonas aeruginosa is a ubiquitous environmental
Gram-negative soil bacterium that is also an important
opportunistic human pathogen causing a variety of differ-
ent nosocomial infections including pneumonia, catheter
and urinary tract infections as well as sepsis in burn
wound and immunocompromised patients [1]. Moreover,
P. aeruginosa is the most prevalent and significant pul-
monary pathogen in patients with cystic fibrosis causing
eventually fatal lung disease [2]. The inability to success-
fully clear P. aeruginosa infections through antibiotic
treatment is a major contributor to the complicated and
often severe outcome of P. aeruginosa infections [3]. It
demonstrates high intrinsic resistance to antibiotics and
an ability to develop even higher resistance through muta-
tion, acquisition of genetic elements, and adaptation to
environmental conditions, e.g. through biofilm formation
on surfaces.
P. aeruginosa also possesses a large arsenal of virulence-
related factors. Among others are a type II, III and VI
secretion system and their associated effector proteins such
as extracellular proteases and phospholipases and the Type
III secreted toxins ExoU, S, T and Y. In addition, they have
flagella and type IV pili that are involved in motility and
host cell adhesion [4-6]. P. aeruginosa also regulates the
gene expression of most virulence factors including genes
involved in iron acquisition (e.g. pyoverdine), toxin produc-
tion (hydrogen cyanide), exopolysaccharide biosynthesis or
biofilm formation in a cell density dependant manner
termed quorum sensing mediated by the two master regu-
lators LasR and RhlR [4,7,8]. Although some virulence
factors seem to be host or site specific, the majority are
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involved in multi-host infections in a variety of different
non-mammalian and mammalian organisms including
amoebae, flies, nematodes, rodents and humans [9-11].
The coordinated control of the production of virulence
and antibiotic resistance factors and the ability to adapt to
various environmental changes is a likely and important
reason that P. aeruginosa is a successful and common
pathogen. The genome sequence of this microorganism
revealed that more than 500 genes, representing nearly
10% of the genome, have a putative role in regulation [1].
In addition to conventional regulators involved in transcrip-
tion of particular genes, e.g. sigma factors, repressors, activa-
tors or two-component response regulators, P. aeruginosa
possesses several additional proteins that modulate transla-
tion, protein biosynthesis and degradation, etc. Here we have
defined the role of the GTPase TypA in the lifestyle of
P. aeruginosa.
TypA, also named BipA, belongs to a superfamily of
ribosome-binding GTPases within the TRAFAC class
(translation factors) of GTPases [12-14]. GTPases are
widely distributed molecular switches found across all
bacterial species, and generally cycle between a GDP-
bound “off” state and a GTP-bound “on” state [14,15].
Collectively they are involved in the regulation of mul-
tiple cellular processes and can play important roles in
translation, ribosome biogenesis and assembly, tRNA
modification, protein translocation, cell polarity, cell div-
ision and signaling events [14,16]. Since GTPases are
widely conserved in prokaryotes and play an essential
role in many important bacterial processes, they are an
attractive target for novel antibiotic development [17].
TypA is highly conserved in bacteria and shares
sequence homologies to other GTPases like elongation
factor G. It is found in many pathogens of significant
public health importance including Vibrio cholera,
Yersinia pestis and Mycobacterium tuberculosis [13].
Although its precise function is still poorly understood,
TypA has been suggested to be involved in the regula-
tion of virulence and stress responses in pathogenic
Escherichia coli [18,19] and Salmonella enterica Serovar
Typhimurium [15], and stress responses in non-pathogenic
Sinorhizobium meliloti [20] and Bacillus subtilis [21]. Open
reading frame PA5117 is annotated as the GTPase TypA,
exhibits 75% sequence homology to TypA/BipA from E.
coli [13], and plays a role in swarming motility and biofilm
formation in P. aeruginosa PAO1 [22]. However, the role
of TypA in pathogenesis of P. aeruginosa is still unknown.
Here we constructed a knock-out mutant of typA in P.
aeruginosa PA14 and demonstrated the involvement of
TypA in the pathogenesis of P. aeruginosa using differ-
ent in vitro and in vivo infection model systems. Consist-
ent with these data, we showed using gene expression
analysis that several virulence-associated genes were
down-regulated in a TypA mutant during host-pathogen
interaction. We also found that TypA plays a role in
antibiotic resistance to a variety of different antibiotics
and initial attachment leading to subsequent biofilm
formation in P. aeruginosa PA14.
Results
TypA is involved in P. aeruginosa virulence
Previously, we showed that a mutation in the typA gene
led to a defect in particular virulence-associated features
such as swarming and biofilm formation in P. aeruginosa
PAO1 [22]. To further investigate the involvement of
TypA in the pathogenesis of P. aeruginosa, we constructed
a site-directed typA knock-out mutant in P. aeruginosa
strain PA14. Strain PA14 is capable of infecting a wide
range of organisms including the amoeba D. discoideum
[23,24] and the nematode C. elegans [4] and was therefore
more suitable for virulence analysis using in vivo model
systems in comparison to strain PAO1.
Detailed analyses of virulence attenuation of the PA14
typA mutant using the unicellular eukaryotic model or-
ganism D. discoideum revealed a consistent, statistically
significant (P < 0.001 by Mann Whitney test) 2-fold
reduction in the numbers of amoebae required to form a
plaque when compared to wild type strain PA14
(Figure 1). The virulence phenotype could be completely
restored to wild type level by heterologous expression of
the cloned typA gene in strain PA14 typA::ptypA+. In
comparison, a similar 2-fold reduction in numbers of
amoebae was determined when analyzing PA14 trans-
poson mutant ID29579 obtained from the Harvard PA14
mutant library [25] with a defect in the pscC gene, which
is an essential part of the Type III secretion system
machinery [26], as a control (Figure 1). To exclude the
fact that a simple growth deficiency of the typA mutant
is responsible for the attenuated virulence phenotype of
PA14 typA, we performed growth analyses at 23°C and
37°C in M9 minimal medium using a Tecan plate reader
under shaking conditions. At both temperatures no
significant growth defect was observed (data not shown).
Since phagocytosis of pathogens by macrophages is a
crucial factor in the human immune defense system, we
quantitatively analyzed in vitro uptake of PA14 WT and
respective mutant strains using human macrophages in
a gentamicin protection assay. We determined a more
than 2-fold increase in internalization of the typA and
the pscC mutant strain in comparison to cells of PA14
WT and complemented strain PA14 typA::ptypA+
(Figure 2). This result was in accord with the virulence
defect observed in the amoeba model of infection, which
is similarly based on phagocytic killing of bacterial cells.
To better understand the mechanism of virulence defi-
ciency in the typA mutant, we additionally determined
virulence in a nematode infection model using C. elegans
as host organism under slow killing conditions. In contrast
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to the Type III secretion based killing of unicellular
eukaryotic hosts like amoebae or macrophages, nematode
killing is rather dependent on quorum sensing related
virulence features in P. aeruginosa [4,27]. When feeding
C. elegans with PA14 wild type, typA mutant and
complemented PA14 typA::ptypA+ strain, we observed a
similar worm killing rate for all tested strains with only
marginal differences between PA14 wild type and typA
knock-out mutant at day 4 of the incubation time
(Figure 3).
TypA is involved in rapid attachment and biofilm
formation
The ability to form biofilms is a known and important fac-
tor in the pathogenesis of P. aeruginosa. To assess the
ability of the typA mutant to develop biofilms, static mi-
crotiter assays were performed to show that PA14 typA
displayed with approximately 20% reduction a statistically
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Figure 1 D. discoideum plate killing assay. Each point represents the number of amoebae required to form a plaque on the bacterial lawn of
P. aeruginosa PA14 strains after 5 days of incubation. The typA and pscC mutants had a major defect in this virulence model of infection, which
was statistically significant as measured with the Mann Whitney test (*** p < 0.001, n = 9).
Figure 2 Uptake of P. aeruginosa by human macrophages.
Strains were incubated with 1.5 × 105 cells/ml macrophages for 1 h
at an MOI of 10. Subsequently, extracellular and attached bacteria
were killed by treatment with gentamicin, and macrophages were
lysed with Triton X-100 and lysates plated to enumerate viable
intracellular bacteria. Results are expressed as the percentage of
intracellular bacteria that were recovered relative to the PA14 WT.
The box plots (median, thick line in the box) represent the mean of
3 independent biological repeats, each assayed minimum in
duplicate (n =≥6). *** indicates a statistically significant difference
(p < 0.001), between the typA and pscC mutant and PA14 WT as
determined by Whitney Mann test.
Figure 3 P. aeruginosa virulence towards C. elegans worms.
(a) Slow killing: Kaplan-Meier survival plots of worms fed with P.
aeruginosa PA14 control (n = 320) (squares), PA14 typA mutant (n = 277)
(diamonds) and the complemented strain PA14 typA::ptypA+ mutant
(n = 319) (triangles). Each value reported for the assay is the mean of
measurements of nine samples from three independent experiments.
Neidig et al. BMC Microbiology 2013, 13:77 Page 3 of 10
http://www.biomedcentral.com/1471-2180/13/77
significant (P < 0.001 by Mann Whitney test) impairment
in biofilm formation at 24 hours (Figure 4) in comparison
to the PA14 WT. This biofilm defect could be
complemented by heterologous expression of wild type
typA in strain PA14 typA::ptypA+. To analyze whether this
biofilm formation phenotype emerged during the initial
adherence phase or later during biofilm growth, a rapid
attachment assay was carri d out. The mutant PA14 typA
exhibited with approximately 20% reduction a statistically
significant (P < 0.001 by Mann Whitney test) defect in
adherence which was similar to the biofilm phenotype.
However, the investigation of flagellum-mediated swim-
ming and swarming motility as well as the type IV pilus-
mediated twitching motility, which are all involved in
attachment and subsequent biofilm development, revealed
no differences between mutant and wild type strain (data
not shown) ruling out defects in the biosynthesis and
function of these cellular appendages in the typA mutant.
Antibiotic susceptibility testing
Since recent studies have demonstrated a role for TypA
in multidrug resistance in E. coli [28], we studied the im-
pact of the typA gene in antibiotic resistance of P.
aeruginosa against a variety of different antimicrobial
compounds. As shown in Table 1, the typA mutant
exhibited a consistent 2-fold increase in susceptibility to
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Figure 4 Defects in attachment and biofilm formation in the typA mutant. (A) Requirement for typA in rapid attachment. Attachment was
determined using diluted overnight cultures for 60 min at 37°C. Adhered cells were stained with crystal violet. (B) Requirement for typA in static
biofilm formation. Cells were grown for 24 h at 37°C in polystyrene microtiter plates containing BM2 medium with 0.5% (w/v) casamino acids.
Microtiter wells were washed several times during incubation to remove planktonic bacteria. Adherent biofilms were stained with crystal violet,
followed by ethanol solubilization of the crystal violet and quantification (A595nm) of stained wells. The box plots (median, thick line in the box)
represent the mean of 3 independent biological repeats, each assayed in quintuplicate (n = 15). *** indicates a statistically significant difference
(p < 0.001), between the typA mutant and PA14 WT as determined by Whitney Mann test.
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the cationic peptides polymyxin B and colistin, the ß-
lactam antibiotics ceftazidime and meropenem, as well
as tetracycline in comparison to the parent strain. This
altered susceptibility could be complemented by intro-
ducing wild type copies of typA into the mutant strain.
No change in susceptibility was observed regarding the
fluoroquinolone ciprofloxacin, the aminoglycoside tobra-
mycin, and the cationic host defence peptide LL-37
(Table 1).
Reduced virulence of PA14 typA due to down-regulation
of the Type III secretion system
Previous studies have shown, that uptake by and killing of
eukaryotic host cells is highly dependent on the Type III
secretion system in P. aeruginosa [5,29,30]. To analyze the
potential molecular basis for reduced virulence of the typA
mutant observed in our experiments, we investigated gene
expression of known virulence-associated genes in P.
aeruginosa using qRT-PCR on bacterial RNA of wild type
and typA mutant strain isolated during host-pathogen
interaction with D. discoideum. These studies revealed
that under the tested conditions, genes coding for the syn-
thesis, function and regulation of the Type III secretion
system, were significantly down-regulated in the typA
mutant compared to wild type (Table 2). This observed
down-regulation of important virulence-related genes is
consistent with the noticed virulence defects in the cellu-
lar infection studies with D. discoideum and human mac-
rophages as hosts.
Discussion
In this study, we have shown that TypA is involved in
virulence of P. aeruginosa by analyzing the consequences
of a typA knock-out on phagocytic amoebae and human
macrophages as well as the interaction with the
nematode C. elegans. Moreover, TypA also contributes
to resistance to different antibiotics as well as attach-
ment and biofilm formation in P. aeruginosa.
TypA is a highly conserved prokaryotic GTPase
exhibiting structural homologies to translation factor
GTPases such as EF-G and LepA and is described to
associate with the ribosomes under normal bacterial
growth [15,31]. In enteropathogenic E. coli (EPEC),
TypA co-ordinates the expression of key stress and viru-
lence factors including flagella, Type III secretion system
as well as the LEE and the espC pathogenicity islands
[18,32] by regulating gene expression of major regulators
such as Ler, which in turn controls these respective
pathogenicity islands. Consequently, it has been sug-
gested that TypA is on a relatively high level in the com-
plex regulatory hierarchy of virulence regulation in this
organism [18,32]. In contrast, analysis in Mycobacterium
tuberculosis revealed that TypA does not act as a viru-
lence regulator in this human pathogen, ruling out a
general involvement of this protein in virulence regula-
tion in pathogenic bacteria [33]. However, our results
demonstrate that TypA plays a role in the pathogenesis
of P. aeruginosa. The typA knock-out mutant exhibited
a significant virulence deficiency in both the amoebae
infection model and the macrophage uptake studies.
These defects were comparable to a pscC mutant with a
disrupted Type III secretion system and consistent with
the down-regulation of Type III secretion genes during
host-pathogen interaction. The Type III secretion system
of Gram-negative bacteria is an important factor of
pathogenesis and is involved in manipulating eukaryotic
cells by injecting effector proteins into the host [27] and
impacts diretly on bacterial uptake by phagocytic cells
[30]. In P. aeruginosa, this complex, needle-like machin-
ery is encoded by 36 genes and an important factor for
the survival during interaction with phagocytic amoebae
or human macrophages, among others [5,29,30]. Using
qRT-PCR, we observed the down-regulation of selected
genes participating in different aspects of Type III secre-
tion, including pscC (outer membrane ring), pscJ (basal
substructure), pscT (translocation), and pcrV (needle-tip
Table 1 MICs of different antibiotics towards
P. aeruginosa PA14 WT, PA14 typA mutant and
complemented mutant PA14 typA::ptypA+a
MIC (μg/ml)
Antibiotic PA14 WT PA14 typA PA14 typA::ptypA+
Ciprofloxacin 0.03 0.03 0.03
Meropenem 2 1 2
Ceftazidime 4 2 4
Tetracycline 8 4 8
Tobramycin 0.25 0.25 0.25
Polymyxin B 0.5 0.25 0.5
Colistin 0.25 0.125 0.25
LL-37 16 16 16
aMICs were determined by serial 2-fold dilutions in MH-medium. The MIC
represents the concentration at which no growth was visually observed after
24 h of incubation at 37°C. The values shown are the modes of 4 to 6
independent experiments.
Table 2 Gene expression of selected Type III secretion
genes in the typA mutant compared to that in wild type
PA14 using RT-qPCR
Gene Fold change in gene expression in the typA mutant
relative to wild typea
T3SS
exsA −3.1 ± 0.5
pscC −2.3 ± 0.4
pscJ −3.5 ± 0.3
pscT −5.1 ± 0.3
pcrV −5.8 ± 0.6
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complex). The transcription of Type III secretion genes
is tightly regulated by ExsA in P. aeruginosa. This mas-
ter regulator controls both, the synthesis of the secretion
system as well as effector protein production, and inter-
acts in concert with the global cyclic AMP and Gac
regulatory systems [5,34]. Our studies showed that in
addition to genes involved in assembly of the secretion
apparatus, expression of exsA was also significantly
down-regulated in the typA mutant compared to wild
type cells. To identify, if increasing Type III secretion
activity is sufficient to complement our virulence pheno-
type, we heterologously expressed the exsA gene using
plasmid pUCP20::exsA+ in the typA mutant and obtained
an identical number of amoebae required for plaque for-
mation in both mutant and wild type PA14 harboring
pUCP20::exsA (data not shown). These findings suggest
that, like in E. coli, TypA is part of the complex regulatory
cascade involved in controlling Type III secretion in P.
aeruginosa by impacting expression of genes involved in
regulation and assembly of the secretion machinery. Since
TypA is a GTPase associated with the ribosomes, a further
down-regulation of the Type III secretion machinery at
the translational level might also be possible; this could
result in an even stronger impairment of the Type III
secretion system.
Previously, it has been shown that the Type III secre-
tion system including its associated virulence effectors
does not play a noticeable role in nematode killing
[4,35], which is rather dependent on quorum sensing
related virulence factors such as RhlR and LasR [27,36].
Thus, it is not surprising, that a mutation in typA with a
down-regulation in the Type III secretion system did not
result in significant virulence attenuation in our studied
infection model. Additional analyses of quorum sensing
dependent production of the extracellular protease LasB
and toxin pyocyanin did not reveal a significant differ-
ence between wild type and mutant strain (data not
shown) demonstrating that TypA does, most likely, not
affect quorum sensing in P. aeruginosa PA14.
TypA was first described to be involved in human bac-
tericidal/permeability-increasing protein BPI, a cationic
host defence peptide from human neutrophils, resistance
in S. typhimurium and E. coli [37,38]. Although we were
not able to detect any differences regarding resistance to
cationic human host defence peptide LL-37, we found that
TypA is also participating in resistance against a variety of
clinically important antibiotics such as ß-lactam, tetracyc-
line and peptides antibiotics in P. aeruginosa. Due to this
wide range of different antimicrobials with unrelated
modes of action, it is likely that the involvement of TypA
in antibiotic stress resistance is rather unspecific and
could be based on the fact that TypA is part of a more
general stress response resulting in resistance. This would
be in accordance with earlier studies showing the
involvement of TypA in a wide variety of very different
stress responses in a number of pathogenic and non-
pathogenic microorganisms, among other stress factors
were antimicrobials, low pH, oxidative or detergent stress
[20,37,38].
Biofilm formation is a crucial factor in the pathogen-
esis of P. aeruginosa and is involved in many chronic
infections including chronic lung infections of cystic
fibrosis patients or foreign body part infections [39]. Bio-
film development is a sequential process initiated by the
attachment of planktonic cells to a surface, followed by
formation of microcolonies and biofilm maturation. Bac-
teria grown in biofilms exhibit high resistance against
antimicrobial agents, are protected from the host im-
mune response and are notoriously difficult to eradicate
[39-41]. Although the typA mutant was able to form
biofilms, we observed a more than 20% reduction in bio-
film mass compared to wild type cells. By analyzing the
initial adhesion phase of biofilm development, we identi-
fied that this reduction in biofilm is, at least in parts,
due to a significant impairment in rapid attachment of
the typA mutant in the respective microtiter plate assay.
This impairment in attachment results in less bacterial
cells initiating biofilm formation and subsequently lower
biofilm growth, which could not be restored to wild type
levels during further biofilm development. Interestingly,
it was shown previously that TypA is involved in adher-
ence to biotic surfaces and interaction of enteropatho-
genic E. coli with epithelial cells [19] and the symbiotic
interaction of S. meliloti with the nodules of the legume
Medicago truncatula [20] indicating a role of TypA in
cell-cell contact. Biofilm initiation and cell adhesion are
rather complex processes influenced by a large number
of proteins and factors, among others are flagellum- and
type IV pilus-mediated bacterial motility and attach-
ment, respectively. Although we have recently shown,
that TypA is involved in swarming motility in P.
aeruginosa strain PAO1 [22], we did not observe any
impairment in swimming, swarming or twitching motility
in the PA14 typA mutant suggesting a mechanism not re-
lated to a defect in flagella or type IV pili biogenesis and
function, respectively, is responsible for the impairment in
adhesion and biofilm initiation in this mutant.
Conclusions
In this study, we were able to demonstrate the involve-
ment of TypA in the pathogenesis of P. aeruginosa by ana-
lyzing the consequences of a typA knock-out. This typA
mutant exhibited reduced virulence towards phagocytic
amoebae and increased uptake by human macrophages,
impaired cell attachment and subsequent biofilm forma-
tion and a reduction in antimicrobial resistance to ß-
lactam, tetracycline and antimicrobial peptide antibiotics.
The typA mutant exhibited a dysregulation of genes
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involved in regulation and assembly of the Type III secre-
tion system, consistent with the observed phenotypes and
role in virulence regulating Type III secretion system.
Methods
Organisms, plasmids, primers, and growth conditions
The organisms and plasmids used in this study are listed
in Table 3 and include P. aeruginosa PA14 [25] and
Dictyostelium discoideum Ax2 [24]. The sequences of
DNA primers (Eurofins MWG Operon, Germany) used
in these studies are available upon request. E. coli was
routinely grown in Luria-Bertani (LB) broth, P.
aeruginosa in M9 [23], LB or BM2 [44] medium, and D.
discoideum in HL5 broth medium [45]. D. discoideum
was incubated in cell culture flasks (Greiner Bio One,
Frickenhausen, Germany) at 22.5°C and sub-cultured
twice a week. When required for plasmid or resistance
gene selection or maintenance, gentamicin, ampicillin
and carbenicillin were added at final concentrations of
30, 100 and 200 μg/ml, respectively.
Amoeba plaque assay
In this cellular model system, a more virulent P.
aeruginosa strain will limit the ability of the amoebae to
form a plaque on a bacterial lawn to a greater extent
than a less virulent strain. The assay was performed
according to the method described previously [23].
Briefly, 50 μl of overnight cultures grown in LB medium
were mixed with 200 μl PBS buffer and plated on M9
agar plates. Plates were dried on a laminar flow bench
for 15 min to obtain a dry, even bacterial lawn. Amoe-
bae grown for 2 to 4 days in the respective medium
were harvested by centrifugation at 510 x g for 10 -
minutes, washed and resuspended in PBS buffer. Cells
were adjusted to 8 × 106 cells per ml and kept on ice.
This stock solution was serially diluted and used to
prepare droplets of 5 μl containing between 5 and
20,000 amoebae, which were subsequently spotted
onto the bacterial lawn. Plates were incubated for 5
days at 22.5°C and the highest dilution at which
growth of the amoebae caused a visible plaque of bac-
terial clearance was reported. Three independent ex-
periments performed at least in duplicate were carried
out for each bacterial strain.
Gentamicin protection assay
In vitro internalization of PA14 WT and mutant cells by
human macrophages derived from monocytes (MDM)
was performed as previously described [46] with modifi-
cations. Briefly, mid-logarithmic phase cultures of P.
aeruginosa were washed with complete RPMI medium
and resuspended in 1 ml of the medium. The resuspended
bacteria were added to 1.5 x 105 MDM cells/ml, at a
multiplicity of infection (MOI) of 10, and incubated for
1 h at 37°C. Subsequently, cells were washed with
complete RPMI and incubated with 400 μg/ml of gentami-
cin for 30 min at 37°C to kill the extracellular and
attached bacteria. After gentamicin treatment, MDM cells
were washed and lysed with 0.1% Triton X-100. Lysates
were plated onto LB agar and incubated overnight at
37°C. The next day, colonies were counted and relative
phagocytic uptake was determined by CFU counts. Three
independent experiments with at least duplicates in each
experiment were performed for each bacterial strain.
Caenorhabditis elegans synchronization and virulence assay
The C. elegans wild-type Bristol strain N2 was obtained
from the Caenorhabditis Genetics Center (Minneapolis,
MN, USA). C. elegans were maintained under standard
culturing conditions at 22°C on nematode growth
Table 3 Strains and plasmids used in this study
Strain or plasmid Description and characteristicsa Reference
Strains
P. aeruginosa
PA14 WT Wild type P. aeruginosa PA14 [25]
PA14 typA typA insertion mutant of PA14, Gmr This study
PA14 typA::ptypA+ Complemented mutant PA14 typA harboring plasmid pUCP20::typA+; Gmr, Cbr This study
PA14 pscC pscC transposon mutant ID29579 of the Harvard PA14 mutant library [25]
E. coli
DH5α F–φ80lacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rK– mK+) supE44λ– thi-1 gyrA96 relA Invitrogen
Plasmids
pUCP20 E. coli – Pseudomonas shuttle vector for constitutive expression of cloned genes, Cbr [42]
pEX18Ap Suicide vector for mutant regeneration in Pseudomonas, Ampr/Cbr [43]
pUCP20::typA+ pUCP20 containing the cloned typA gene; Ampr/Cbr This study
pUCP20::exsA+ pUCP20 containing the cloned exsA gene; Ampr/Cbr This study
a Antibiotic resistance phenotypes: Ampr, ampicillin resistance for E. coli; Cbr, carbenicillin resistance for P. aeruginosa; Gmr, gentamicin resistance.
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medium (NGM: 3 g NaCl, 2.5 g peptone, 17 g agar, 5 mg
cholesterol, 1 ml 1 M CaCl2, 1 ml 1 M MgSO4, 25 ml
1 M KH2PO4, H2O to 1 liter) agar plates with E. coli
OP50 as a food source [47]. Synchronous cultures of
worms were generated after worm adult population
exposure to a sodium hypochlorite/sodium hydroxide
solution as previously described [48] and adapted [49].
The resulting eggs were incubated at 22°C on an E. coli
OP50 lawn until the worms reached the L4 (48 hours)
life stage (confirmed by light microscopy). Bacterial
lawns used for C. elegans survival assays were prepared
by spreading 50 μl of P. aeruginosa strains on 35 mm
NGM conditioned Petri dishes supplemented with
0.05 mg ml−1 5-fluoro-20-deoxyuridine. This nucleotide
analog blocks the development of the next C. elegans
generation by inhibition of DNA synthesis. The plates
were incubated overnight at 37°C and then placed at
room temperature for 4 h. Fifteen to twenty L4 synchro-
nized worms were harvested by resuspension in M9
buffer (3 g KH2PO4, 6 g NaHPO4, 5 g NaCl, 1 ml 1 M
MgSO4, H2O to 1 liter), plated on the 35 mm assay Petri
dishes and incubated at 22°C. Worm survival was scored
after 1 h, 24 h and on each subsequent day, using an
Axiovert S100 optical microscope (Zeiss, Oberkochen,
Germany) equipped with a Nikon digital Camera DXM
1200 F (Nikon Instruments, Melville, NY, USA). Worms
were considered dead when they remained static without
grinder movements for 20 s. The results were expressed
as the percentage of living worms and were the average of
three independent assays performed in triplicate.
Growth curves
Overnight cultures grown in LB medium were diluted
into M9 medium to obtain equal starting optical dens-
ities at 600 nm (OD600). Five-μl portions of these
cultures were added to 195 μl of fresh M9 medium in
96-well microtiter plates. The growth of the cultures at
37°C and 23°C under shaking conditions was monitored
with a Tecan Infinite F200 Pro.
Plasmid and typA knock-out mutant generation
For the construction and complementation of a typA
knock-out mutant in P. aeruginosa PA14 the typA gene
(gene number PA_67560) was amplified by PCR using
EcoRI and HindIII flanked oligonucleotides, respectively,
and subsequently cloned behind the lac promoter in the
broad host range vector pUCP20, resulting in pUCP20::
typA+. For the heterologous expression of the exsA gene,
exsA was amplified by PCR using EcoRI and XbaI
flanked oligonucleotides, respectively, and subsequently
cloned into pUCP20, resulting in pUCP20::exsA+. These
plasmids were then transferred into E. coli DH5α by
transformation or P. aeruginosa by electroporation. The
knock-out mutant was obtained according to the
methods described previously [43]. Briefly, the hybrid
plasmid pUCP20::typA+ was digested with SmaI to
delete a 1.1 kb fragment from the typA gene, which was
subsequently replaced with a Ω gentamicin resistance
gene cassette for selection. The disrupted typAΩGm
gene was amplified by PCR and cloned into the suicide
vector pEX18Ap [43] and transferred into P. aeruginosa
PA14 to generate the typA knock-out mutant named P.
aeruginosa PA14 typA by allelic exchange.
MIC determination
MICs were measured using standard broth microdilution
procedures [50] in Mueller Hinton (MH) medium.
Growth was scored following 24 h of incubation at 37°C.
Motility, biofilm and rapid attachment assays
Swimming, swarming and twitching motility were evalu-
ated as described previously [44]. The abiotic solid sur-
face assay was used to measure biofilm formation
according to the previously described method with the
following modifications [51]. Overnight cultures were
diluted 1:100 in BM2 containing 0.5% (w/v) casamino
acids and inoculated into 96-well polystyrene microtiter
plates and incubated at 37°C for 60 min without shaking
to allow bacterial cell adhesion. Subsequently, the micro-
titer wells were washed twice to remove planktonic cells
and new biofilm growth medium was added. This wash-
ing step was repeated after 4 and 16 hours of incubation.
After 24 h, the biofilm was staining using crystal violet
and the absorbance was measured at 595 nm using a
Tecan Infinite F200 Pro.
Rapid attachment of bacterial cells to a surface was
analyzed as described previously [44]. Briefly, overnight
cultures grown in BM2-medium were washed and di-
luted in BM2 medium containing 0.1% (w/v) casamino
acids (CAA) to an OD595nm of 1.0. One hundred μl of
this suspension was used to inoculate each well of a
microtiter plate. Cells were allowed to adhere for 60 min
at 37°C prior to staining with crystal violet.
RNA extraction, cDNA synthesis, and quantitative real-
time PCR (qRT-PCR)
For analysis of virulence gene expression, overnight cul-
tures of P. aeruginosa PA14 WT and the typA mutant
were washed twice and resuspended in PBS buffer and
adjusted to an OD600 of 2.0. For each bacterial cell sus-
pension, 10 μl was mixed with washed amoeba cells of
2-day old D. discoideum cultures at a ratio of 3:1 bacteria
to amoebae and the mixtures were plated on M9 agar
plates. After incubation for 48 h at 22.5°C, cells were
harvested from the agar plate surface, using an inoculation
loop, and were resuspended in M9 medium supplemented
with RNA protect reagent (Qiagen, Germany). To sep-
arate cells of D. discoideum from the bacterial cells, the
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mixtures were centrifuged for 1 min at 1,000 rpm and
the supernatants containing the bacterial cells were
used for RNA extraction.
RNA isolation, cDNA synthesis, and qRT-PCR analysis
were performed as described previously [52] using the
Power SYBR Green PCR Master Mix in an Abi 7300 Real
Time PCR System (Applied Biosystems). All reactions
were normalized to the house keeping gene rpsL. Experi-
ments were repeated with three independent cultures.
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